Activation and inhibition effects of some natural products on human cytosolic CAI and CAII

ArticleAçık Erişim

Özet

Carbonic anhydrases (CAs) play a significant function in diverse pathological and physiological processes. Their inhibitors and activators are suitable molecules to use as a drug in the treatment of different disease. In the present study, seven natural compounds, namely didymin, retusin isoquercitrin, silymarin, verbascoside, teucroside, and 3′-O-methylhypolaetin 7-O-[6′′′-O-acetyl-β-D-allopyranosyl-(1→2)]-6′′-O-acetyl-β-D-glucopyranoside were isolated from Mentha spicata, Sideritis libanotica linearis, Platanus orientalis, Teucrium chamaedrys subsp. chamaedrys, and Silybum marianum. The influences of compounds on the carbonic anhydrase I(hCAI) and II(hCAII) purified from human erythrocytes were tested. Five phenolic compounds acted as an inhibitor on the activity of hCAI, and IC50 values were computed between 18.16 and 172.5 μM. Isozyme hCAII is only inhibited by silymarin with an IC50 value of 43.12 μM. This isoenzyme was effectively activated by five natural compounds with AC50 values in the range of 2.98–18.53 μM. To understand the binding patterns of molecules that show activation effect against hCAII, molecular docking was done using Leadit 2.3.2 software, and calculated between −19.05 and −14.42 (kJ/mol) binding energies. Both in vitro and in silico results demonstrated that the best activators against hCAII were teucroside and isoquercitrin, with AC50 values of 2.98 and 3.17 μM, and binding energies −19.05 and −18.01 (kJ/mol), respectively. According to the ADME results, retusin demonstrated physicochemical and pharmacokinetic properties specific to the drug candidates. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13859Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s00044-019-02329-1Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAdem, Sevki
dc.contributor.authorAkkemik, Ebru
dc.contributor.authorAksit, Hüseyin
dc.contributor.authorGuller, Pınar
dc.contributor.authorTüfekci, Ali Rıza
dc.contributor.authorDemirtas, İbrahim
dc.contributor.authorCiftci, Mehmet
dc.date.accessioned2026-10-18T20:28:39.612127076Z
dc.date.available2026-10-18T20:28:39.612127076Z
dc.date.issued2019
dc.description.abstractCarbonic anhydrases (CAs) play a significant function in diverse pathological and physiological processes. Their inhibitors and activators are suitable molecules to use as a drug in the treatment of different disease. In the present study, seven natural compounds, namely didymin, retusin isoquercitrin, silymarin, verbascoside, teucroside, and 3′-O-methylhypolaetin 7-O-[6′′′-O-acetyl-β-D-allopyranosyl-(1→2)]-6′′-O-acetyl-β-D-glucopyranoside were isolated from Mentha spicata, Sideritis libanotica linearis, Platanus orientalis, Teucrium chamaedrys subsp. chamaedrys, and Silybum marianum. The influences of compounds on the carbonic anhydrase I(hCAI) and II(hCAII) purified from human erythrocytes were tested. Five phenolic compounds acted as an inhibitor on the activity of hCAI, and IC50 values were computed between 18.16 and 172.5 μM. Isozyme hCAII is only inhibited by silymarin with an IC50 value of 43.12 μM. This isoenzyme was effectively activated by five natural compounds with AC50 values in the range of 2.98–18.53 μM. To understand the binding patterns of molecules that show activation effect against hCAII, molecular docking was done using Leadit 2.3.2 software, and calculated between −19.05 and −14.42 (kJ/mol) binding energies. Both in vitro and in silico results demonstrated that the best activators against hCAII were teucroside and isoquercitrin, with AC50 values of 2.98 and 3.17 μM, and binding energies −19.05 and −18.01 (kJ/mol), respectively. According to the ADME results, retusin demonstrated physicochemical and pharmacokinetic properties specific to the drug candidates. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
dc.description.sponsorshipConflict of interest This research was financed Cankiri Karatekin University (Project No: BAP 2012-13).
dc.identifier.doi10.1007/s00044-019-02329-1
dc.identifier.eissn1554-8120
dc.identifier.endpage722
dc.identifier.issn1054-2523
dc.identifier.issue5
dc.identifier.scopus2-s2.0-85064092041
dc.identifier.startpage711
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13859
dc.identifier.volume28
dc.identifier.wosWOS:000464742900008
dc.language.isoen
dc.publisherBirkhauser Boston
dc.relation.ispartofMedicinal Chemistry Research
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectActivation
dc.subjectCarbonic anhydrase
dc.subjectDocking
dc.subjectInhibition
dc.subjectNatural product
dc.subject3 o methylhypolaetin 7 o [6''' o acetyl beta dextro allopyranosyl(1-2)] 6'' o acetyl beta dextro glucopyranoside
dc.subjectacteoside
dc.subjectcarbonate dehydratase I
dc.subjectcarbonate dehydratase II
dc.subjectcarbonate dehydratase inhibitor
dc.subjectdidymin
dc.subjectisoquercitrin
dc.subjectretusin isoquercitrin
dc.subjectsilymarin
dc.subjectteucroside
dc.subjectunclassified drug
dc.subjectArticle
dc.subjectcomputer model
dc.subjectcontrolled study
dc.subjectdrug activation
dc.subjectdrug binding
dc.subjectdrug isolation
dc.subjectenzyme activity
dc.subjectenzyme inhibition
dc.subjecterythrocyte
dc.subjectgermander
dc.subjectheteronuclear multiple bond correlation
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC50
dc.titleActivation and inhibition effects of some natural products on human cytosolic CAI and CAII
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus19
rdl.citation.wos17
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)